GLP-1, Ozempic, Wegovy -Mounjaro,
Patients should seek emergency medical help (call 999) if they experience: Difficulty breathing, wheezing, or throat tightness Swelling of the face, lips, tongue, or throat (angioedema) Widespread urticarial rash (hives) developing rapidly Dizziness, fainting, or rapid heartbeat suggesting anaphylaxis These symptoms typically occur within minutes to hours of administration, most commonly with injectable preparations
Competitive athletes should avoid it entirely unless willing to accept the consequences of a possible drug test failure
The pathogenesis of IAV infection has been associated with oxidative stress 27
As research into GLP-1 RAs continues, these drugs could become a cornerstone in a comprehensive, multi-faceted approach to managing diabetes complicationshelping patients not only control their blood sugar but also protect their kidneys and heart
It will be carried out under the surveillance and guidelines of the Good Clinical Practice and in accordance with the Helsinki Declaration
.png)
